Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
The role of ‘Modified Mediterranean Diet’ and quantum therapy in Alzheimer’s disease primary prevention
Authors
M. Marchionni
S. Stagnaro
S. Caramel
Publication date
01-01-2014
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 1/2014
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-013-0435-7

Other articles of this Issue 1/2014

The journal of nutrition, health & aging 1/2014 Go to the issue

Commentary

Frailty: The quest for new domains, clinical definitions and subtypes. Is this justified on new evidence emerging?

OriginalPaper

Is obesity a marker of robustness in vulnerable hospitalized aged populations? Prospective, multicenter cohort study of 1 306 acutely ill patients

OriginalPaper

A path model of sarcopenia on bone mass loss in elderly subjects

OriginalPaper

Utility of 123I-FP-CIT SPECT for dementia diagnoses and therapeutic strategies in elderly patients

OriginalPaper

Validation of the nutrition screening tool ‘Seniors in the Community: Risk Evaluation for Eating and Nutrition, version II’ among octogenarians

OriginalPaper

Risk of in-hospital mortality following emergency department admission: Results from the geriatric EDEN cohort study

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits